Orchestra BioMed (OBIO) CFO reports 3,071-share tax withholding

Orchestra BioMed Holdings, Inc. (OBIO) reported an insider equity transaction by its Chief Financial Officer on 11/25/2025.

Rhea-AI Filing Summary

Orchestra BioMed Holdings, Inc. (OBIO) reported an insider equity transaction by its Chief Financial Officer on 11/25/2025. The filing shows that 3,071 shares of common stock were withheld by the company at a price of $5.35 per share to cover tax withholding obligations arising from the vesting of restricted stock units.

According to the disclosure, no shares were sold in the open market in connection with this event. After this tax-related withholding, the reporting person directly beneficially owns 463,615 shares of Orchestra BioMed common stock.

Insider Trade Summary

Exercise Price or Tax Liability: 3,071 shares

Exercise Price or Tax Liability 1 txn

Insider Taylor Andrew Lawrence

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock, par value $0.0001 per share	3,071	$5.35	$16K

Holdings After Transaction: Common Stock, par value $0.0001 per share — 463,615 shares (Direct)

Footnotes (1)

1. F1. Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Orchestra BioMed (OBIO) report in this Form 4?

The Form 4 reports that the Chief Financial Officer had 3,071 shares of Orchestra BioMed common stock withheld by the company to satisfy tax withholding obligations related to vesting restricted stock units on 11/25/2025.

Were any Orchestra BioMed (OBIO) shares sold on the market in this transaction?

No. The filing states that no shares were sold in the market as a result of the vesting of restricted stock units and the related tax withholding.

How many Orchestra BioMed (OBIO) shares does the insider own after this transaction?

Following the reported tax withholding, the reporting person directly beneficially owns 463,615 shares of Orchestra BioMed common stock.

What was the price used for the Orchestra BioMed (OBIO) tax withholding shares?

The 3,071 shares withheld to cover taxes were valued at a price of $5.35 per share, as disclosed in the Form 4.

What is the role of the reporting person at Orchestra BioMed (OBIO)?

The reporting person is an officer of Orchestra BioMed Holdings, Inc., serving as the companys Chief Financial Officer.

Why were Orchestra BioMed (OBIO) shares withheld instead of paying cash taxes?

The explanation notes that the withheld 3,071 shares represent shares retained by the issuer to satisfy tax withholding obligations triggered by the vesting of restricted stock units, a common method for covering associated taxes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/26/2025 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Taylor Andrew Lawrence

(Last) (First) (Middle)

C/O ORCHESTRA BIOMED HOLDINGS, INC.

150 UNION SQUARE DRIVE

(Street)

NEW HOPE PA 18938

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Orchestra BioMed Holdings, Inc. [ OBIO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001 per share	11/25/2025		F(1)		3,071	D	$5.35	463,615	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations.

	/s/ Andrew Taylor	11/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.